Clients have their choice of computational biologists and bioinformaticians in Boston. They choose Diamond Age because it provides:

Actionable insights, not just data. Diamond Age’s analyses are rooted in a deep understanding of fundamental molecular biology and therapeutics development. They generate real, meaningful results that companies can use right away.

Bleeding-edge techniques. Diamond Age doesn’t shy away from challenges – single-cell RNA-seq, RNA splicing analysis, advanced proteomics, statistical genetics at large scale – it seeks them out.

A faster innovation cycle. Data scientists, biologists, and therapeutics experts often speak different scientific “languages” – a challenge that can slow down product development. Diamond Age can act as a translator and convener, enabling collaboration and speeding up the process.

Reliable, reproducible code. Diamond Age works quickly, but never, ever sacrifices quality. All code is meticulously documented to enable reproducibility. 


Why “Diamond Age?”

We live in a world in which molecular technology is transforming all aspects of life. So do the protagonists of Neal Stephenson’s futuristic and acclaimed fourth novel, “The Diamond Age: Or, A Young Lady’s Illustrated Primer,” an ode to the importance of innovation and the value of knowledge. The diamond age is what follows the information age — after we learn to manage information, mine our data, and turn that data into knowledge (and, in the case of the book, build skyscrapers from diamonds). The company is named in tribute.